Skip to content

Clinical trials

Lung Diseases trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Russia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20092
20102
20111
20132
20142
20151
20162
20172
20181
20202
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated3
Active, not recruiting2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Novartis Pharmaceuticals6
AO GENERIUM2
Celgene1
Eli Lilly and Company1
NPO Petrovax1
Population Health Research Institute1
R-Pharm1
R-Pharm International, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases22
Respiratory Tract Diseases13
Bronchial Diseases7
Lung Diseases, Obstructive7
Asthma5
Cystic Fibrosis5
COVID-193
Fibrosis3
Lung Neoplasms3
Neoplasms3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.